- Trials with a EudraCT protocol (810)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (32)
810 result(s) found for: Nausea.
Displaying page 1 of 41.
EudraCT Number: 2015-003956-32 | Sponsor Protocol Number: POSTPAL | Start Date*: 2016-03-15 | |||||||||||||||||||||||||||||||
Sponsor Name:Umeå University | |||||||||||||||||||||||||||||||||
Full Title: Effects of postoperative palonosetron in ambulatory patients identified with high risk for postdischarge nausea and vomiting (PDNV) – a randomized controlled trial with comparison to placebo. | |||||||||||||||||||||||||||||||||
Medical condition: Nausea and vomiting in the home (after discharge) after day-case surgery under general anesthesia- | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: SE (Completed) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-003070-33 | Sponsor Protocol Number: DANSAC-RCT | Start Date*: 2015-11-30 | |||||||||||||||||||||
Sponsor Name:Odense University Hospital | |||||||||||||||||||||||
Full Title: DANSAC-RCT: Fosaprepitant in patients with advanced cancer not receiving chemotherapy or irradiation; A multicenter, randomized, double-blind, placebo-controlled study. | |||||||||||||||||||||||
Medical condition: Emesis | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-000351-33 | Sponsor Protocol Number: 2005/2:5 | Start Date*: 2007-07-26 | |||||||||||
Sponsor Name:Karolinska Universitetssjukhuset Solna | |||||||||||||
Full Title: Will paracetamol reduce the opioid requirements and the (opioid)related postoperative nausea? | |||||||||||||
Medical condition: Paracetamol is used as a complimentary painrelief. Using sealed envelopes, 140 patients will be randomly assigned to receive either 1g paracetamol as tablets (Panodil® Glaxo Smith Kline) or 1g plac... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-003189-33 | Sponsor Protocol Number: NHLPal | Start Date*: 2006-10-31 | |||||||||||
Sponsor Name:G.I.S.L. - GRUPPO ITALIANO STUDIO LINFOMI | |||||||||||||
Full Title: Phase II study with Palonosetron alone in preventing chemotherapy-induced nausea and vomiting in untreated patients with aggressive Non Hodgkins Lymphomas who underwent moderately emetogenic chemo... | |||||||||||||
Medical condition: preventing chemotherapy-induced nausea and vomiting in untreated patients with aggressive Non Hodgkins Lymphomas who underwent moderately emetogenic chemotherapy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000658-39 | Sponsor Protocol Number: AkupresSNP | Start Date*: 2016-07-11 |
Sponsor Name:Region Jönköpings län | ||
Full Title: Randomized multicenter study of Acupressure combined with personalized antiemetics based on genetic variations (SNPs) in women undergoing neoadjuvant or adjuvant chemotherapy EC / FEC against breas... | ||
Medical condition: Nausea in conjuction with neoadjuvant or adjuvant chemotherapy (FEC/EC) for patients with breast cancer. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-005216-28 | Sponsor Protocol Number: VNK115640 | Start Date*: 2012-04-05 | |||||||||||
Sponsor Name:GlaxoSmithKline | |||||||||||||
Full Title: A Multicenter, Randomized, Single-blind, Active-controlled, Parallel Group, Phase II Study to Evaluate the Efficacy, Safety, and Tolerability of a Single Intravenous (6 mg, 12 mg, 18 mg, 24 mg or 3... | |||||||||||||
Medical condition: Post-operative nausea and vomiting (PONV) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) GB (Prematurely Ended) PL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-001339-37 | Sponsor Protocol Number: 2008-001339-37 | Start Date*: 2008-04-10 | ||||||||||||||||
Sponsor Name:AZIENDA OSPEDALIERA S. MARIA DI TERNI | ||||||||||||||||||
Full Title: Aprepitant in the prevention of cisplatin-induced delayed emesis: a double-blind randomized study | ||||||||||||||||||
Medical condition: patiens with different cancers submitted to single dose of cisplatin chemotherapy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-001237-95 | Sponsor Protocol Number: 2008-001237-95 | Start Date*: 2008-04-10 | ||||||||||||||||
Sponsor Name:AZIENDA OSPEDALIERA S. MARIA DI TERNI | ||||||||||||||||||
Full Title: Aprepitant in the prevention of delayed emesis induced by moderately emetogenic chemotherapy (cyclophosphamide + anthracycline) in breast cancer patients: a double-blind randomized study | ||||||||||||||||||
Medical condition: patients with breast cancer receiving chemotherapy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004853-27 | Sponsor Protocol Number: Palonosetron | Start Date*: 2007-09-05 | |||||||||||
Sponsor Name:OSPEDALE POLICLINICO S. MATTEO | |||||||||||||
Full Title: A phase IV monocentre study to evaluate palonosetron in nausea/vomiting prevention in patients with breast or colon cancer, treated with moderately aemotogenic chemotherapic agents | |||||||||||||
Medical condition: nausea and vomiting prevention | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003260-39 | Sponsor Protocol Number: ML16633 | Start Date*: 2016-08-05 | |||||||||||
Sponsor Name:F. Hoffmann-La Roche AG | |||||||||||||
Full Title: Intravenous Granisetron (Kytril) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or Adenotonsillectomy | |||||||||||||
Medical condition: Prevention of Post-operative Nausea and Vomiting (PONV) in pediatric subjects | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-013543-11 | Sponsor Protocol Number: 2009057 | Start Date*: 2009-10-19 |
Sponsor Name:James Cook University Hospital | ||
Full Title: A comparison of nausea with two routine ways of managing low blood pressure after delivery of the baby during spinal anaesthesia for Caesarean section. | ||
Medical condition: We are investigating nausea associated with hypotension caused by spinal anaesthesia in healthy women undergoing elective Caesarean section. NICE recommend phenylephrine in this population. The aim... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002428-34 | Sponsor Protocol Number: ANE-DEX-2019 | Start Date*: 2019-09-27 | |||||||||||
Sponsor Name:HOSPITAL CLINICO SAN CARLOS | |||||||||||||
Full Title: ONE CENTRE, DOUBLE BLIND, ONE CENTRE, RANDOMIZED CLINICAL TRIAL, IN TWO PARALLEL GROUPS TO EVALUATE THE EFICACY IN THE PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING OF DEXAMETHASONE VERSUS METHIL... | |||||||||||||
Medical condition: Postoperative nausea and vomiting after not urgent laparoscopic cholecystectomy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-005928-13 | Sponsor Protocol Number: 52/2005 | Start Date*: Information not available in EudraCT |
Sponsor Name:Landspitali-University Hospital | ||
Full Title: Prospective randomized double blind trial on the use of Scopoderm patch for control of post-operative nausea and vomitting in patients undergoing gynecologic laparoscopic procedures. | ||
Medical condition: Post-operative nausea and vomiting in patients undergoing gynecologic laparoscopic procedures. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: IS (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-003730-20 | Sponsor Protocol Number: NEPA-15-31 | Start Date*: 2020-09-17 | ||||||||||||||||
Sponsor Name:Helsinn Healthcare SA | ||||||||||||||||||
Full Title: A multicenter, multinational, randomized, double-blind, pharmacokinetic and pharmacodynamic (PK/PD) dose-finding study of oral netupitant administered concomitantly with oral palonosetron in pediat... | ||||||||||||||||||
Medical condition: nausea and vomiting associating with emetogenic chemotherapy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: Outside EU/EEA | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-003992-30 | Sponsor Protocol Number: DP10019 | Start Date*: 2016-03-08 | |||||||||||
Sponsor Name:Acacia Pharma Ltd | |||||||||||||
Full Title: Randomised, double-blind, placebo-controlled study of APD421 (amisulpride for IV injection) as treatment of established post-operative nausea and vomiting, in patients who have had prior prophylaxis | |||||||||||||
Medical condition: Post-operative nausea and vomiting | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-013923-43 | Sponsor Protocol Number: Nichel-SNAS/09 | Start Date*: 2010-03-03 | ||||||||||||||||||||||||||
Sponsor Name:LOFARMA | ||||||||||||||||||||||||||||
Full Title: Studio in doppio cieco controllato con placebo sulla efficacia e tollerabilita' della terapia desensibilizzante con nichel in pazienti affetti da sindrome sistemica da allergia al nichel | ||||||||||||||||||||||||||||
Medical condition: Pazienti affetti da SNAS | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: IT (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-022746-24 | Sponsor Protocol Number: TS-P04834 | Start Date*: 2012-05-07 | ||||||||||||||||
Sponsor Name:Tesaro, Inc. | ||||||||||||||||||
Full Title: A Phase 3, Multicenter, Randomized, Double-Blind, Active-Controlled Study of the Safety and Efficacy of Rolapitant for the Prevention of Chemotherapy- Induced Nausea and Vomiting (CINV) in Subject... | ||||||||||||||||||
Medical condition: Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Moderately Emetogenic Chemotherapy (MEC) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Completed) LV (Completed) ES (Completed) BE (Completed) CZ (Completed) PL (Completed) BG (Completed) SK (Completed) PT (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-022971-79 | Sponsor Protocol Number: PALO-10-14 | Start Date*: 2011-05-23 | ||||||||||||||||
Sponsor Name:Helsinn Healthcare SA | ||||||||||||||||||
Full Title: A Multicenter, Double-blind, Double-dummy, Randomized, Parallel Group, Stratified Study to Evaluate the Efficacy and Safety of a Single IV Dose of Palonosetron Compared to a Single IV Dose of Ondan... | ||||||||||||||||||
Medical condition: Postoperative nausea and vomiting (PONV) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: CZ (Completed) PL (Completed) HU (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-002041-59 | Sponsor Protocol Number: DP10018 | Start Date*: 2015-09-11 | |||||||||||
Sponsor Name:Acacia Pharma Ltd | |||||||||||||
Full Title: Randomised, double-blind, placebo-controlled study of APD421 (amisulpride for IV injection) as treatment of established post-operative nausea and vomiting, in patients who have had no prior prophyl... | |||||||||||||
Medical condition: Post-operative nausea and vomiting | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-004789-20 | Sponsor Protocol Number: GDW07/08 | Start Date*: 2008-09-05 |
Sponsor Name:UZLEUVEN | ||
Full Title: ” A comparative double-blind placebo-controlled study between alizapride and ondansetron for the prevention of postoperative nausea and vomiting.” | ||
Medical condition: Prevention of post-operative nausea and vomiting. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.